← Back to Search

N/A

Computerized Cognitive Tests for Neurological Disease

N/A
Recruiting
Led By Alexander Chervinsky, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants will be male or female and between the ages of 21 and 65 years old.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

This trial is testing three new computerized tests that will measure brain/cognitive functioning. The tests will be given to both healthy controls and neurologically impaired patients to see how well they work.

Who is the study for?
This trial is for men and women aged 21-65, both healthy individuals and those with significant brain findings on neuroimaging. Participants must have good perception and motor skills to do the tests but can't join if they have severe dementia or lack the necessary perceptual/motor abilities.Check my eligibility
What is being tested?
The study is testing three new computer-based cognitive function tests against traditional paper-and-pencil methods. It aims to see if these digital tasks are more effective by comparing results from healthy controls and patients with neurological impairments.See study design
What are the potential side effects?
Since this trial involves non-invasive neuropsychological testing, there are no direct physical side effects expected from participating in this study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 21 and 65 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Score on President Recognition Test
Score on Railroad Test
Score on Swamp Test

Trial Design

2Treatment groups
Active Control
Group I: Non-CNI participantsActive Control10 Interventions
Identified from the department of Rehabilitation, Psychiatry, and Medicine and referred to the research staff via in-person communication, email or staff message
Group II: Cerebral neurological illness (CNI) participantsActive Control10 Interventions
Identified from the department of Rehabilitation, Psychiatry, and Medicine and referred to the research staff via in-person communication, email or staff message

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,367 Previous Clinical Trials
839,561 Total Patients Enrolled
Alexander Chervinsky, PhDPrincipal InvestigatorNYU Langone Health

Media Library

Computer-based Neuropsychological Tool (N/A) Clinical Trial Eligibility Overview. Trial Name: NCT03502603 — N/A
Neurological Disease Research Study Groups: Non-CNI participants, Cerebral neurological illness (CNI) participants
Neurological Disease Clinical Trial 2023: Computer-based Neuropsychological Tool Highlights & Side Effects. Trial Name: NCT03502603 — N/A
Computer-based Neuropsychological Tool (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03502603 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~21 spots leftby Dec 2024